References
- Sun H, Zou X, Liu L. Epidemiological factors of stroke: a survey of the current status in China. J Stroke 2013;15:109–14
- Chen XR, Liao SJ, Ye LX, et al. Neuroprotective effect of chondroitinase ABC on primary and secondary brain injury after stroke in hypertensive rats. Brain Res 2014;1543:324–33
- Loos M, Dihne M, Block F. Tumor necrosis factor-alpha expression in areas of remote degeneration following middle cerebral artery occlusion of the rat. Neuroscience 2003;122:373–80
- Ghosh N, Ghosh R, Bhat ZA, et al. Advances in herbal medicine for treatment of ischemic brain injury. Nat Prod Commun 2014;9:1045–55
- Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893–903
- Zhao H, Wang R, Wu X, et al. Erythropoietin delivered via intra-arterial infusion reduces endoplasmic reticulum stress in brain microvessels of rats following cerebral ischemia and reperfusion. J Neuroimmune Pharmacol 2015;10:153–61
- Qi Z, Dong W, Shi W, et al. Bcl-2 phosphorylation triggers autophagy switch and reduces mitochondrial damage in limb remote ischemic conditioned rats after ischemic stroke. Transl Stroke Res 2015;6:198–206
- Wahl AS, Omlor W, Rubio JC, et al. Neuronal repair. Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke. Science 2014;344:1250–5
- Martin JL, Ma D, Hossain M, et al. Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. Br J Anaesth 2007;98:236–40
- Mi YJ, Hou B, Liao QM, et al. Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity. Cell Death Differ 2012;19:1175–86
- Guo F, Wang H, Li L, et al. A novel domain of amino-Nogo-A protects HT22 cells exposed to oxygen glucose deprivation by inhibiting NADPH oxidase activity. Cell Mol Neurobiol 2013;33:443–52
- Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003;4:703–13
- Domeniconi M, Cao Z, Spencer T, et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 2002;35:283–90
- Enkel T, Berger SM, Schonig K, et al. Reduced expression of nogo-a leads to motivational deficits in rats. Front Behav Neurosci 2014;8:10
- Petrasek T, Prokopova I, Bahnik S, et al. Nogo-A downregulation impairs place avoidance in the Carousel maze but not spatial memory in the Morris water maze. Neurobiol Learn Mem 2014;107:42–9
- GrandPre T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002;417:547–51
- Wang Q, Gou X, Jin W, et al. TAT-mediated protein transduction of Nogo extracellular peptide 1-40 and its biological activity. Cell Mol Neurobiol 2009;29:97–108
- Gou X, Wang Q, Yang Q, et al. TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke. J Drug Target 2011;19:86–95
- Wang Q, Gou X, Xiong L, et al. Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. Anesthesiology 2008;108:1071–80
- Cheatwood JL, Emerick AJ, Schwab ME, Kartje GL. Nogo-A expression after focal ischemic stroke in the adult rat. Stroke 2008;39:2091–8
- Ohtaki H, Ylostalo JH, Foraker JE, et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 2008;105:14638–43
- Wacker BK, Park TS, Gidday JM. Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2. Stroke 2009;40:3342–8
- Wang Q, Peng Y, Chen S, et al. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 2009;40:2157–64
- Zhang HP, Yuan LB, Zhao RN, et al. Isoflurane preconditioning induces neuroprotection by attenuating ubiquitin-conjugated protein aggregation in a mouse model of transient global cerebral ischemia. Anesth Analg 2010;111:506–14
- Homi HM, Mixco JM, Sheng H, et al. Severe hypotension is not essential for isoflurane neuroprotection against forebrain ischemia in mice. Anesthesiology 2003;99:1145–51
- Zhang ZH, Yu LJ, Hui XC, et al. Hydroxy-safflor yellow A attenuates Abeta1-42-induced inflammation by modulating the JAK2/STAT3/NF-kappaB pathway. Brain Res 2014;1563:72–80
- Kruk M, Tendera K, Biala G. Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test. Pharmacol Rep 2011;63:1372–82
- Adachi M, Barrot M, Autry AE, et al. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 2008;63:642–9
- Clark SM, Sand J, Francis TC, et al. Immune status influences fear and anxiety responses in mice after acute stress exposure. Brain Behav Immun 2014;38:192–201
- Farr SA, Ripley JL, Sultana R, et al. Antisense oligonucleotide against GSK-3beta in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radic Biol Med 2014;67:387–95
- Oztanir MN, Ciftci O, Cetin A, et al. The beneficial effects of 18beta-glycyrrhetinic acid following oxidative and neuronal damage in brain tissue caused by global cerebral ischemia/reperfusion in a C57BL/J6 mouse model. Neurol Sci 2014;35:1221–8
- Molina V, Ravelo Y, Noa M, et al. Therapeutic effects of policosanol and atorvastatin against global brain ischaemia–reperfusion injury in gerbils. Indian J Pharm Sci 2013;75:635–41
- Alexander MP, Lafleche G, Schnyer D, et al. Cognitive and functional outcome after out of hospital cardiac arrest. J Int Neuropsychol Soc 2011;17:364–8
- Torgersen J, Strand K, Bjelland TW, et al. Cognitive dysfunction and health-related quality of life after a cardiac arrest and therapeutic hypothermia. Acta Anaesthesiol Scand 2010;54:721–8
- Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000;403:434–9
- GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000;403:439–44
- Papadopoulos CM, Tsai SY, Alsbiei T, et al. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol 2002;51:433–41
- Z'Graggen WJ, Metz GA, Kartje GL, et al. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci 1998;18:4744–57
- Kilic E, Elali A, Kilic U, et al. Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab 2010;30:969–84
- Guo F, Jin WL, Li LY, et al. M9, A novel region of amino-Nogo-A, attenuates cerebral ischemic injury by inhibiting NADPH oxidase-derived superoxide production in mice. Cns Neurosci Ther 2013;19:319–28
- Buee L, Bussiere T, Buee-Scherrer V, et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 2000;33:95–130
- Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 1975;72:1858–62
- Sanchez C, Diaz-Nido J, Avila J. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol 2000;61:133–68
- Woolf NJ, Zinnerman MD, Johnson GV. Hippocampal microtubule-associated protein-2 alterations with contextual memory. Brain Res 1999;821:241–9
- Latchney SE, Masiulis I, Zaccaria KJ, et al. Developmental and adult GAP-43 deficiency in mice dynamically alters hippocampal neurogenesis and mossy fiber volume. Dev Neurosci 2014;36:44–63